1. Home
  2. VTSI vs LPCN Comparison

VTSI vs LPCN Comparison

Compare VTSI & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$4.60

Market Cap

51.1M

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$2.56

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
LPCN
Founded
1993
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.1M
61.8M
IPO Year
1999
2011

Fundamental Metrics

Financial Performance
Metric
VTSI
LPCN
Price
$4.60
$2.56
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$5.00
N/A
AVG Volume (30 Days)
80.4K
776.3K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.18
EPS
0.02
N/A
Revenue
$185,971.00
$1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
$27.30
$92.00
P/E Ratio
$235.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$1.81
52 Week High
$7.47
$12.37

Technical Indicators

Market Signals
Indicator
VTSI
LPCN
Relative Strength Index (RSI) 61.36 30.75
Support Level $4.21 N/A
Resistance Level $4.68 $3.40
Average True Range (ATR) 0.26 0.41
MACD 0.10 -0.26
Stochastic Oscillator 75.52 9.88

Price Performance

Historical Comparison
VTSI
LPCN

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: